Ignacio
Gil Bazo
Ikertzailea 2022-(e)ra arte
Pfizer (United States)
Nueva York, Estados UnidosPfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2009
-
Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array
British Journal of Cancer, Vol. 101, Núm. 11, pp. 1876-1883